Back to Search Start Over

A feasibility study of NIR fluorescent image-guided surgery in head and neck cancer basedon the assessment of optimum surgical timeas revealed through dynamic imaging.

Authors :
Junkichi Yokoyama
Mitsuhisa Fujimaki
Shinichi Ohba
Takashi Anzai
Ryota Yoshii
Shin Ito
Masataka Kojima
Katsuhisa Ikeda
Source :
OncoTargets & Therapy; 2013, Vol. 6, p325-330, 6p
Publication Year :
2013

Abstract

Background: In order to minimize surgical stress and preserve organs, endoscopic or robotic surgery is often performed when conducting head and neck surgery. However, it is impossible to physically touch tumors or to observe diffusely invaded deep organs through the procedure of endoscopic or robotic surgery. In order to visualize and safely resect tumors even in these cases, we propose using an indocyanine green (ICG) fluorescence method for navigation surgery in head and neck cancer. Objective: To determine the optimum surgical time for tumor resection after the administration of ICG based on the investigation of dynamic ICG fluorescence imaging. Methods: Nine patients underwent dynamic ICG fluorescence imaging for 360 minutes, assessing tumor visibility at 10, 30, 60, 120, 180, and 360 minutes. All cases were scored according to near-infrared (NIR) fluorescence imaging visibility scored from 0 to 5. Results: Dynamic NIR fluorescence imaging under the HyperEye Medical System indicated that the greatest contrast in fluorescent images between tumor and normal tissue could be observed from 30 minutes to 1 hour after the administration of ICG. The optimum surgical time was determined to be between 30 minutes to 2 hours after ICG injection. These findings are particularly useful for detection and safe resection of tumors invading the parapharyngeal space. Conclusion: ICG fluorescence imaging is effective for the detection of head and neck cancer. Preliminary findings suggest that the optimum timing for surgery is from 30 minutes to 2 hours after the ICG injection. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
11786930
Volume :
6
Database :
Complementary Index
Journal :
OncoTargets & Therapy
Publication Type :
Academic Journal
Accession number :
87481406
Full Text :
https://doi.org/10.2147/OTT.S42006